amniokenteesi

Amniokenteesi, also known as amniocentesis, is a medical procedure used to obtain a sample of amniotic fluid from the amniotic sac surrounding a developing fetus. This procedure is typically performed between 15 and 20 weeks of pregnancy to diagnose genetic disorders, chromosomal abnormalities, and certain infections. The amniotic fluid contains fetal cells, which can be analyzed to detect genetic conditions such as Down syndrome, cystic fibrosis, and sickle cell anemia.

The procedure is usually performed under ultrasound guidance. A needle is inserted through the mother's abdomen and into the amniotic sac. A small amount of amniotic fluid, typically about 10-20 milliliters, is withdrawn. The sample is then sent to a laboratory for analysis. The procedure is generally considered safe and has a low risk of complications, although there is a small risk of miscarriage, infection, and bleeding.

Amniokenteesi is an important tool in prenatal care, providing valuable information about the health of the fetus. It allows for early detection of genetic disorders, enabling parents to make informed decisions about their pregnancy. However, it is not without risks, and the decision to undergo the procedure should be carefully considered in consultation with a healthcare provider.